uti and glp-1 Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, Outcomes Semaglutide and Urinary Tract Infections:
Description
Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
The study findings may spark treatment innovations for depression and anxiety.
Former seven-time Mr
*Based on peer-reviewed clinical studies
Underwriters are treating your clients' dramatic weight loss as a red flag, not a health victory
